Robust radiative cooling via surface phonon coupling-enhanced emissivity from SiO2 micropillar arrays

Silicon dioxide (SiO2) is a prominent candidate for radiative cooling applications due to its low absorption in solar wavelengths (0.25-2.5 µm) and exceptional stability. However, its bulk phonon-polariton band results in a strong reflection peak in the atmospheric transparency window (8-13 µm), making it difficult to meet the requirements for sub-ambient passive radiative cooling. Herein, we demonstrate that SiO2 micropillar arrays can effectively suppress infrared reflection at 8-13 µm and enhance the infrared emissivity by optimizing the micropillar array structure. We created a pattern with a height, spacing, and diameter of approximately 1.45 µm, 0.15 µm, and 0.35 µm, respectively, on top of a bulk SiO2 substrate using reactive ion etching. The resulting surface phonon coupling of the micropillar array led to an increase in the thermal emissivity from 0.79 to 0.94. Outdoor tests show that the SiO2 cooler with an optimized micropillar array can generate an average temperature drop of 5.5 °C throughout the daytime underneath an irradiance of 843.1 W/m^2 at noon. Furthermore, the micropillar arrays endow the SiO2 cooler with remarkable hydrophobic properties, attributed to the formation of F/C compounds introduced during the etching process. Finally, we also replicated the micropillar pattern onto the surface of industrial optical solar reflectors (OSRs), demonstrating similar emissivity and hydrophobicity enhancements. Our findings revealed an effective strategy for modifying the thermal management features of durable SiO2 layers, which can be harnessed to cool OSRs and other similar sky-facing devices

A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors

Pediatric patients with recurrent and refractory cancers are in most need for new treatments. This study developed patient-derived-xenograft (PDX) models within the European MAPPYACTS cancer precision medicine trial (NCT02613962). To date, 131 PDX models were established following heterotopical and/or orthotopical implantation in immunocompromised mice: 76 sarcomas, 25 other solid tumors, 12 central nervous system tumors, 15 acute leukemias, and 3 lymphomas. PDX establishment rate was 43%. Histology, whole exome and RNA sequencing revealed a high concordance with the primary patient's tumor profile, human leukocyte-antigen characteristics and specific metabolic pathway signatures. A detailed patient molecular characterization, including specific mutations prioritized in the clinical molecular tumor boards are provided. Ninety models were shared with the IMI2 ITCC Pediatric Preclinical Proof-of-concept Platform (IMI2 ITCC-P4) for further exploitation. This PDX biobank of unique recurrent childhood cancers provides an essential support for basic and translational research and treatments development in advanced pediatric malignancies

A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors

Pediatric patients with recurrent and refractory cancers are in most need for new treatments. This study developed patient-derived-xenograft (PDX) models within the European MAPPYACTS cancer precision medicine trial (NCT02613962). To date, 131 PDX models were established following heterotopical and/or orthotopical implantation in immunocompromised mice: 76 sarcomas, 25 other solid tumors, 12 central nervous system tumors, 15 acute leukemias, and 3 lymphomas. PDX establishment rate was 43%. Histology, whole exome and RNA sequencing revealed a high concordance with the primary patient's tumor profile, human leukocyte-antigen characteristics and specific metabolic pathway signatures. A detailed patient molecular characterization, including specific mutations prioritized in the clinical molecular tumor boards are provided. Ninety models were shared with the IMI2 ITCC Pediatric Preclinical Proof-of-concept Platform (IMI2 ITCC-P4) for further exploitation. This PDX biobank of unique recurrent childhood cancers provides an essential support for basic and translational research and treatments development in advanced pediatric malignancies

Effect of Enhanced Electron Withdrawal on the Cohesion of Cr-Pd Hemichelates

Two new trimetallic Cr-Pd hemichelates containing a fluorenyl moiety and two trans arene-bound Cr(CO)(3) moieties were synthesized and fully characterized. Their molecular structures obtained by X-ray diffraction analysis do not show major differences - in interatomic bond lengths within the Pd coordination sphere - when compared to previously reported bimetallic analogues. Theoretical investigations were performed using methods of the Density Functional Theory (ZORA-PBE-D3(BJ)/all electron TZP level, EDA, ETS-NOCV and QTAIM-IQA) to analyse the influence of a second Cr(CO)(3) moiety in the process of formation of the Cr-Pd hemichelate. Theory shows that despite the extensive charge delocalization in the anion of trans-bistricarbonylchromium(fluorene), the formation of a stable hemichelate is still possible albeit requiring a moderate energy payload to funnel charge density towards the formation of the benzylic carbon-palladium bond. IQA analyses of hemichelates show the important role of attractive electrostatic interactions in the dominantly noncovalent Cr(CO)(3)-Pd interactions

Reflections on academic appointments in pediatrics

ERMAInternational audienc